Table of Contents Global RNAi for Therapeutic Market Research Report 2020, Forecast to 2025 1 Market Overview 1.1 RNAi for Therapeutic Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 RNAi for Therapeutic Segment by Type 1.2.1 siRNA 1.2.2 miRNA 1.2.3 shRNA 1.3 Market Analysis by Application 1.3.1 Cancer 1.3.2 Cardiovascular 1.3.3 HBV 1.3.4 Other 1.4 Overview of Global RNAi for Therapeutic Market 1.4.1 Global RNAi for Therapeutic Revenue (2015-2025) 1.4.2 Global RNAi for Therapeutic Production and Capacity (2015-2025) 1.4.3 North America RNAi for Therapeutic Status and Prospect (2015-2025) 1.4.4 Europe RNAi for Therapeutic Status and Prospect (2015-2025) 1.4.5 Japan RNAi for Therapeutic Status and Prospect (2014-2025) 1.4.6 China RNAi for Therapeutic Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): RNAi for Therapeutic Industry Impact 1.6.1 How the Covid-19 is Affecting the RNAi for Therapeutic Industry 1.6.2 RNAi for Therapeutic Business Impact Assessment - Covid-19 1.6.3 Market Trends and RNAi for Therapeutic Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global RNAi for Therapeutic Market Competition by Manufacturer 2.1 Global RNAi for Therapeutic Sales and Market Share by Manufacturer (2018-2020) 2.2 Global RNAi for Therapeutic Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global RNAi for Therapeutic Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 RNAi for Therapeutic Manufacturer Market Share 2.5 Top 10 RNAi for Therapeutic Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into RNAi for Therapeutic Market 2.7 Key Manufacturers RNAi for Therapeutic Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of RNAi for Therapeutic Industry Key Manufacturers 3.1 Alnylam Pharmaceuticals 3.1.1 Company Details 3.1.2 Product Information 3.1.3 Alnylam Pharmaceuticals RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 Alnylam Pharmaceuticals News 3.2 Arbutus Biopharma (Tekmira) 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Arbutus Biopharma (Tekmira) RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Arbutus Biopharma (Tekmira) News 3.3 Arrowhead 3.3.1 Company Details 3.3.2 Product Information 3.3.3 Arrowhead RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 Arrowhead News 3.4 Dicerna Pharmaceuticals 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Dicerna Pharmaceuticals RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Dicerna Pharmaceuticals News 3.5 Mirna Therapeutics 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Mirna Therapeutics RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Mirna Therapeutics News 3.6 Quark Pharmaceuticals 3.6.1 Company Details 3.6.2 Product Information 3.6.3 Quark Pharmaceuticals RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.6.4 Main Business Overview 3.6.5 Quark Pharmaceuticals News 3.7 RXi Pharmaceuticals 3.7.1 Company Details 3.7.2 Product Information 3.7.3 RXi Pharmaceuticals RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.7.4 Main Business Overview 3.7.5 RXi Pharmaceuticals News 3.8 Silence Therapeutics 3.8.1 Company Details 3.8.2 Product Information 3.8.3 Silence Therapeutics RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.8.4 Main Business Overview 3.8.5 Silence Therapeutics News 3.9 Benitec Biopharma 3.9.1 Company Details 3.9.2 Product Information 3.9.3 Benitec Biopharma RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.9.4 Main Business Overview 3.9.5 Benitec Biopharma News 3.10 miRagen Therapeutics 3.10.1 Company Details 3.10.2 Product Information 3.10.3 miRagen Therapeutics RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.10.4 Main Business Overview 3.10.5 miRagen Therapeutics News 3.11 Sylentis 3.11.1 Company Details 3.11.2 Product Information 3.11.3 Sylentis RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.11.4 Main Business Overview 3.11.5 Sylentis News 3.12 Gradalis 3.12.1 Company Details 3.12.2 Product Information 3.12.3 Gradalis RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.12.4 Main Business Overview 3.12.5 Gradalis News 3.13 Sirnaomics 3.13.1 Company Details 3.13.2 Product Information 3.13.3 Sirnaomics RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.13.4 Main Business Overview 3.13.5 Sirnaomics News 3.14 Silenseed 3.14.1 Company Details 3.14.2 Product Information 3.14.3 Silenseed RNAi for Therapeutic Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.14.4 Main Business Overview 3.14.5 Silenseed News 4 Global RNAi for Therapeutic Market Size Categorized by Regions (2015-2020) 4.1 Global RNAi for Therapeutic Sales Market Share by Region 4.2 Global RNAi for Therapeutic Revenue Market Share by Region (2015-2019) 4.3 Global RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015-2020) 4.4 North America RNAi for Therapeutic Market Size Detail 4.4.1 North America RNAi for Therapeutic Sales Growth Rate (2015-2020) 4.4.2 North America RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015-2020) 4.5 Europe RNAi for Therapeutic Market Size Detail 4.5.1 Europe RNAi for Therapeutic Sales Growth Rate (2015-2020) 4.5.2 Europe RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015-2020) 4.6 Japan RNAi for Therapeutic Market Size Detail 4.6.1 Japan RNAi for Therapeutic Sales Growth Rate (2015-2020) 4.6.2 Japan RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015-2020) 4.7 China RNAi for Therapeutic Market Size Detail 4.7.1 China RNAi for Therapeutic Sales Growth Rate (2015-2020) 4.7.2 China RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2015-2020) 5 Global RNAi for Therapeutic Market Segment by Type 5.1 Global RNAi for Therapeutic Revenue, Sales and Market Share by Type (2015-2020) 5.1.1 Global RNAi for Therapeutic Sales and Market Share by Type (2015-2020) 5.1.2 Global RNAi for Therapeutic Revenue and Market Share by Type (2015-2020) 5.2 siRNA Sales Growth Rate and Price 5.2.1 Global siRNA Sales Growth Rate (2015-2020) 5.2.2 Global siRNA Price (2015-2020) 5.3 miRNA Sales Growth Rate and Price 5.3.1 Global miRNA Sales Growth Rate (2015-2020) 5.3.2 Global miRNA Price (2015-2020) 5.4 shRNA Sales Growth Rate and Price 5.4.1 Global shRNA Sales Growth Rate (2015-2020) 5.4.2 Global shRNA Price (2015-2020) 6 Global RNAi for Therapeutic Market Segment by Application 6.1 Global RNAi for Therapeutic Sales Market Share by Application (2015-2020) 6.2 Cancer Sales Growth Rate (2015-2020) 6.3 Cardiovascular Sales Growth Rate (2015-2020) 6.4 HBV Sales Growth Rate (2015-2020) 6.5 Other Sales Growth Rate (2015-2020) 7 RNAi for Therapeutic Related Market Analysis 7.1 Upstream Analysis 7.1.1 Macro Analysis of Upstream Markets 7.1.2 Key Players in Upstream Markets 7.1.3 Upstream Market Trend Analysis 7.1.4 RNAi for Therapeutic Manufacturing Cost Analysis 7.2 Downstream Market Analysis 7.2.1 Macro Analysis of Down Markets 7.2.2 Key Players in Down Markets 7.2.3 Downstream Market Trend Analysis 7.2.4 Sales Channel, Distributors, Traders and Dealers 8 Global RNAi for Therapeutic Market Forecast 8.1 Global RNAi for Therapeutic Sales, Revenue Forecast 8.1.1 Global RNAi for Therapeutic Sales Growth Rate Forecast (2020-2025) 8.1.2 Global RNAi for Therapeutic Revenue and Growth Rate Forecast (2020-2025) 8.1.3 Global RNAi for Therapeutic Price and Trend Forecast (2020-2025) 8.2 Global RNAi for Therapeutic Sales Forecast by Region (2020-2025) 8.2.1 North America RNAi for Therapeutic Sales, Revenue Forecast (2020-2025) 8.2.2 Europe RNAi for Therapeutic Sales, Revenue Forecast (2020-2025) 8.2.3 Japan RNAi for Therapeutic Production, Revenue Forecast (2020-2025) 8.2.4 China RNAi for Therapeutic Production, Revenue Forecast (2020-2025) 9 Research Findings and Conclusion 10 Appendix

List of Tables and Figures Figure RNAi for Therapeutic Picture Table Global RNAi for Therapeutic Sales by Type Figure Global Sales Market Share of RNAi for Therapeutic by Product Type in 2019 Table Breakdown of RNAi for Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3) Figure RNAi for Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure siRNA Picture Figure miRNA Picture Figure shRNA Picture Table Global RNAi for Therapeutic Sales by Application Figure Global RNAi for Therapeutic Sales Market Share by Application in 2019 Figure Cancer Picture Figure Cardiovascular Picture Figure HBV Picture Figure Other Picture Table RNAi for Therapeutic Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global RNAi for Therapeutic Revenue (Million US$) (2015-2025) Figure Global RNAi for Therapeutic Production (K Units) (2015-2025) Figure North America RNAi for Therapeutic Revenue (Million US$) Growth Rate (2015-2025) Figure Europe RNAi for Therapeutic Revenue (Million US$) Growth Rate (2015-2025) Figure Japan RNAi for Therapeutic Revenue (Million US$) Growth Rate (2014-2025) Figure China RNAi for Therapeutic Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global RNAi for Therapeutic Sales by Manufacturer (2018-2020) Figure Global RNAi for Therapeutic Sales Market Share by Manufacturer in 2019 Table Global RNAi for Therapeutic Revenue by Manufacturer (2018-2020) Figure Global RNAi for Therapeutic Revenue Market Share by Manufacturer in 2019 Table Global RNAi for Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 RNAi for Therapeutic Manufacturer (Revenue) Market Share in 2019 Figure Top 10 RNAi for Therapeutic Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into RNAi for Therapeutic Market Table Key Manufacturers RNAi for Therapeutic Product Type Table Mergers & Acquisitions Planning Table Alnylam Pharmaceuticals Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Alnylam Pharmaceuticals Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Alnylam Pharmaceuticals RNAi for Therapeutic Market Share (2018-2020) Table Alnylam Pharmaceuticals Main Business Table Alnylam Pharmaceuticals Recent Development Table Arbutus Biopharma (Tekmira) Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Arbutus Biopharma (Tekmira) Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Arbutus Biopharma (Tekmira) RNAi for Therapeutic Market Share (2018-2020) Table Arbutus Biopharma (Tekmira) Main Business Table Arbutus Biopharma (Tekmira) Recent Development Table Arrowhead Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Arrowhead Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Arrowhead RNAi for Therapeutic Market Share (2018-2020) Table Arrowhead Main Business Table Arrowhead Recent Development Table Dicerna Pharmaceuticals Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Dicerna Pharmaceuticals Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Dicerna Pharmaceuticals RNAi for Therapeutic Market Share (2018-2020) Table Dicerna Pharmaceuticals Main Business Table Dicerna Pharmaceuticals Recent Development Table Mirna Therapeutics Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Mirna Therapeutics Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Mirna Therapeutics RNAi for Therapeutic Market Share (2018-2020) Table Mirna Therapeutics Main Business Table Mirna Therapeutics Recent Development Table Quark Pharmaceuticals Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Quark Pharmaceuticals Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Quark Pharmaceuticals RNAi for Therapeutic Market Share (2018-2020) Table Quark Pharmaceuticals Main Business Table Quark Pharmaceuticals Recent Development Table RXi Pharmaceuticals Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of RXi Pharmaceuticals Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure RXi Pharmaceuticals RNAi for Therapeutic Market Share (2018-2020) Table RXi Pharmaceuticals Main Business Table RXi Pharmaceuticals Recent Development Table Silence Therapeutics Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Silence Therapeutics Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Silence Therapeutics RNAi for Therapeutic Market Share (2018-2020) Table Silence Therapeutics Main Business Table Silence Therapeutics Recent Development Table Benitec Biopharma Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Benitec Biopharma Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Benitec Biopharma RNAi for Therapeutic Market Share (2018-2020) Table Benitec Biopharma Main Business Table Benitec Biopharma Recent Development Table miRagen Therapeutics Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of miRagen Therapeutics Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure miRagen Therapeutics RNAi for Therapeutic Market Share (2018-2020) Table miRagen Therapeutics Main Business Table miRagen Therapeutics Recent Development Table Sylentis Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Sylentis Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sylentis RNAi for Therapeutic Market Share (2018-2020) Table Sylentis Main Business Table Sylentis Recent Development Table Gradalis Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Gradalis Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Gradalis RNAi for Therapeutic Market Share (2018-2020) Table Gradalis Main Business Table Gradalis Recent Development Table Sirnaomics Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Sirnaomics Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Sirnaomics RNAi for Therapeutic Market Share (2018-2020) Table Sirnaomics Main Business Table Sirnaomics Recent Development Table Silenseed Company Profile Figure RNAi for Therapeutic Product Picture and Specifications of Silenseed Table RNAi for Therapeutic Production, Price, Revenue and Gross Margin of 2018-2020 Figure Silenseed RNAi for Therapeutic Market Share (2018-2020) Table Silenseed Main Business Table Silenseed Recent Development Table Global RNAi for Therapeutic Sales (K Units) by Region (2015-2020) Table Global RNAi for Therapeutic Sales Market Share by Region (2015-2019) Figure Global RNAi for Therapeutic Sales Market Share by Region (2015-2019) Figure Global RNAi for Therapeutic Sales Market Share by Region in 2018 Table Global RNAi for Therapeutic Revenue (Million US$) by Region (2015-2020) Table Global RNAi for Therapeutic Revenue Market Share by Region (2015-2020) Figure Global RNAi for Therapeutic Revenue Market Share by Region (2015-2020) Figure Global RNAi for Therapeutic Revenue Market Share by Region in 2019 Table Global RNAi for Therapeutic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure North America RNAi for Therapeutic Sales (K Units) Growth Rate (2015-2020) Figure Europe RNAi for Therapeutic Sales (K Units) Growth Rate (2015-2020) Table Europe RNAi for Therapeutic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure Japan RNAi for Therapeutic Sales (K Units) Growth Rate (2015-2020) Table Japan RNAi for Therapeutic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Figure China RNAi for Therapeutic Sales (K Units) Growth Rate (2015-2020) Table China RNAi for Therapeutic Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table Global RNAi for Therapeutic Sales by Type (2015-2020) Table Global RNAi for Therapeutic Sales Market Share by Type (2015-2020) Figure Global RNAi for Therapeutic Sales Market Share by Type in 2019 Table Global RNAi for Therapeutic Revenue by Type (2015-2020) Table Global RNAi for Therapeutic Revenue Market Share by Type (2015-2020) Figure Global RNAi for Therapeutic Revenue Market Share by Type in 2019 Figure Global siRNA Sales Growth Rate (2015-2025) Figure Global siRNA Price (2015-2020) Figure Global miRNA Sales Growth Rate (2015-2025) Figure Global miRNA Price (2015-2020) Figure Global shRNA Sales Growth Rate (2015-2025) Figure Global shRNA Price (2015-2020) Table Global RNAi for Therapeutic Sales Market Share by Application (2015-2020) Figure Global RNAi for Therapeutic Sales Market Share by Application in 2019 Figure Global Cancer Sales Growth Rate (2015-2025) Figure Global Cardiovascular Sales Growth Rate (2015-2025) Figure Global HBV Sales Growth Rate (2015-2025) Figure Global Other Sales Growth Rate (2015-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of RNAi for Therapeutic Table Key Players of Downstream Markets Figure Sales Channel Figure Global RNAi for Therapeutic Production (K Units) Growth Rate Forecast (2020-2025) Figure Global RNAi for Therapeutic Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Global RNAi for Therapeutic Price and Trend Forecast (2020-2025) Table Global RNAi for Therapeutic Sales (K Units) Forecast by Region (2020-2025) Figure Global RNAi for Therapeutic Production Market Share Forecast by Region (2020-2025) Figure North America RNAi for Therapeutic Sales (K Units) Growth Rate Forecast (2020-2025) Figure North America RNAi for Therapeutic Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Europe RNAi for Therapeutic Sales (K Units) Growth Rate Forecast (2020-2025) Figure Europe RNAi for Therapeutic Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Japan RNAi for Therapeutic Production (K Units) Growth Rate Forecast (2020-2025) Figure Japan RNAi for Therapeutic Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure China RNAi for Therapeutic Production (K Units) Growth Rate Forecast (2020-2025) Figure China RNAi for Therapeutic Revenue (Million US$) Growth Rate Forecast (2020-2025) Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

Alnylam Pharmaceuticals Arbutus Biopharma (Tekmira) Arrowhead Dicerna Pharmaceuticals Mirna Therapeutics Quark Pharmaceuticals RXi Pharmaceuticals Silence Therapeutics Benitec Biopharma miRagen Therapeutics Sylentis Gradalis